Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,615,309
+$99,386 QoQ
Shares Held
198,772
0.0% QoQ
Ownership
0.284%
of shares outstanding
% of Portfolio
4.84%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kalehua Capital Management LLC holds $111,070,340 across 22 Biotechnology names. PHVS ranks #9 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XFOR |
X4 Pharmaceuticals, Inc
|
3,722,840 | $15,375,329 | |
| 2 | SRZN |
Surrozen, Inc./DE
|
385,178 | $11,220,235 | |
| 3 | MANE |
Veradermics, Inc
|
145,695 | $9,200,638 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
901,457 | $8,969,497 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
197,072 | $7,900,616 | |
| 6 | ACRS |
Aclaris Therapeutics, Inc.
|
1,832,365 | $6,871,368 | |
| 7 | IKT |
Inhibikase Therapeutics, Inc.
|
3,821,890 | $6,420,775 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
118,524 | $5,813,602 |
All Filings in PHVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,615,309 | 198,772 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,515,923 | 198,772 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||